Valtrex medicine
Doctors have been looking for novel valtrex medicine ways to treat and prevent HIV infection, particularly in poor countries where few can afford modern AIDS drugs and the stigma keeps many from taking them. The study involved researchers from France, England and Burkina Faso and was funded by the French national AIDS research agency, ANRS. Mayaud has received research support from Glaxo. GlaxoSmithKline announced that the valtrex medicine u. There are 4. 3 million new HIV infections worldwide each year. In the study, 140 women from the West African nation of Burkina Faso who were infected with the both the herpes and AIDS viruses received either valacyclovir or dummy pills for three months. Michael Saag, director of the AIDS valtrex medicine center at the University of Alabama at Birmingham. Researchers recently found that circumcision lowers the risk of spreading HIV, and they hope the same will prove true of treating herpes. In the latest study, conducted in Africa and published in todays New England Journal of Medicine, women who took the herpes drug valacyclovir had less HIV in their blood and in their genital secretions. A larger study funded by the Bill and Melinda Gates Foundation is under way that aims to be the definitive word on whether treating herpes patients with acyclovir, the first herpes drug, can slow down HIV transmission. However, scientists generally have found that the more virus someone has, the greater the valtrex medicine risk of transmission. There were no differences in the duration of outbreaks, viral shedding, or signs and symptoms between patients who received 3 days of Valtrex followed by 2 days of a placebo and those who received the full 5-day course. It does open some potential avenues to slowing down the HIV epidemic, said Dr. However, they said such treatment could be useful in preventing HIV transmission in Third World Valtrex medicine countries without access to modern AIDS drugs. Doctors have been looking for novel ways to treat and prevent HIV infection, particularly in poor countries where few can afford modern AIDS drugs and the stigma keeps many from taking them. The study valtrex medicine involved researchers from France, England and Burkina Faso. After being triggered, the herpes simplex virus begins to reproduce, resulting in damage to skin cells that can lead to the characteristic blisters. The treatment group was also less likely to have HIV in their genital tract — 13 percent had detectable virus levels during each visit, compared with Valtrex medicine 27 percent in the placebo group.